AroCell Attends Three Prestigious Events: AACR, EAU Congress and COG Nordics

Apr 16, 2024

Last week AroCell participated in three major events across the medical and research domains. From Paris to San Diego and Copenhagen, our team presented the latest advancements and interacted with industry and scientific leaders in the field.

EAU Congress 2024

In Paris from April 5-8, AroCell’s marketing and clinical team alongside with esteemed partners Prof Thorsten Ecke and Dr. Sarah Weiss from Germany participated in the 39th annual European Association of Urology Congress. With a gathering of over 10,000 urologists and researchers from across the globe, our team presented a poster titled “Effect of hematuria on the performance of BTAstat®, UBC® Rapid, and NMP22 as urine-based biomarker for bladder cancer detection“. This study, conducted in collaboration with our partners concluded that hematuria does not affect the performance of UBC® Rapid.

Read the abstract here: Sarah Weiß

AACR Annual Meeting 2024

At the American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego from April 5-10, our team delivered two impactful poster presentations. Professor Teemu Murtola highlighted the TK 210 ELISAs predictive role of castration resistance in metastatic prostate cancer.  while Kiran Jagarlamudi, CSO from AroCell, delved into the clinical applications of TK 210 ELISA in DLBCL therapy,  The AACR Annual Meeting is renowned as the gathering for cancer research professionals, and this year was no exception. With over 20,000 attendees converging to explore the latest breakthroughs in cancer diagnosis and therapy.

COG Nordics Conference 2024

Navigating the complexities of clinical research can be challenging, especially for smaller companies. At the Clinical Outsourcing Group Nordics conference, on April 9th, AroCell’s Clinical Director, Adintya Putri took the stage to share valuable insights. Her presentation, “Key Opinion Leaders in Clinical Trials: Identifying, Engaging, and Sustaining Meaningful Relationships” provided strategies and best practices for KOL identification and relationship building. With a focus on enhancing patient recruitment and retention.

At AroCell, we’re committed to innovation and new partnerships within the medical community. Our presence at these events highlights our dedication to advancing cancer research and improving patient outcomes.

Adintya Putri presenting at COG Nordics

Presentation at LabRoots 2024

Martin Shaw, Business Development at AroCell, held a presentation on the Thymidine Kinase 1 immunoassay, highlighting its significance as a valuable translational biomarker from drug discovery through to clinical trials. You can see the presentation below....

read more